August 2013


August 30, 2013

Breast Screening MRI May Increase Survival In Certain Women
Screening MRI may improve survival rates for women with family risk factors for breast cancer. But the technology is expensive, especially for younger women, so finding screening alternatives may be beneficial, according to a new study published online in the Journal of the National Cancer Institute.

Read more here.

August 28, 2013

New Study Refutes 2009 Recommendation from the U.S. Preventive Services Task Force
A recent study of the association between missed mammograms and breast cancer stage at diagnosis disputes the U.S. Preventive Services Task Force (USPSTF) recommendation that routine mammograms are unnecessary for women younger than 50 and that biennial screening mammography for women aged 50 to 74 years is sufficient. Dr. Adedayo Onitilo, adjunct clinical associate professor, University of Wisconsin School of Medicine & Public Health, Madison, WI, and the corresponding author of an article about the study in the November 2013 American Journal of Roentgenology, talked with ARRS about those findings.

Read the Q&A with Dr. Onitilo here.

August 20, 2013

BI-RADS 3 Lesions Detected By Ultrasound May Be Mostly Benign
Breast lesions categorized as "probably benign" on supplemental screening ultrasound are rarely malignant and could be re-evaluated at 12 months rather than six -- reducing patient anxiety, follow-up exams, and unnecessary biopsies, according to a study published online in Radiology.

Read more here.

August 15, 2013

Higher MRI Use Linked To Increase In Aggressive Breast Cancer Surgeries
The growing use of MRI in breast cancer patients may be leading to unnecessary breast removal in older women, according to a large new study. Women who received an MRI were more likely to have more aggressive surgery. Among women who underwent breast removal (mastectomy), 12.5 percent of those who had an MRI had both breasts removed, compared with about 4 percent of those who did not have an MRI.

Read more here.

August 9, 2013

Screening Reduces Late-Stage Breast Cancer Rates in Italy
A study of breast cancer screening in 700 municipalities in Italy during an eight-year period showed that the incidence of late-stage breast cancer declined starting in the third year of screening, according to an article published in Cancer.

Click here to read the full article from Cancer.

Mark Helvie, MD, FSBI, Society of Breast Imaging Board of Directors Member, comments:

The authors report a decrease in late- stage breast cancer incidence among 692,824 women invited to organized mammographic screening in Italy involving 700 municipalities. A significant 29% (CI 21-36%) decrease of late-stage disease (defined as pT2-pT4 , that is tumors >2 cm in diameter) was observed among invited women after 7-8 years, although a decrease in incidence was noted as early as years 3-4. The impact for women who were actually screened (not just invited) was not reviewed.

August 9, 2013

Links Found On Triple-Negative Breast Cancer Appearance On MRI, PET/CT
California researchers have found links between the appearance of triple-negative breast cancer on two different imaging modalities, MRI and PET/CT. They believe their findings can help guide therapy for the disease, which occurs less frequently but is typically more deadly than other types of breast cancer, according to a study published online July 22 in Radiology.

Read more here.

August 5, 2013

GE Healthcare Submits PMA For Breast Tomosynthesis System
GE Healthcare has begun shipping its SenoClaire tomosynthesis system in Europe and has put the final touches on a regulatory application in the U.S.

Read the full article here.

August 5, 2013

ACR Responds to New York Times Article on Redefining Cancer Diagnosis
On August 4, the New York Times published a letter by Barbara Monsees, MD, chair of the American College of Radiology Breast Imaging Commission, and Carol Lee, MD, chair of the ACR Breast Imaging Communications Committee, in response to a recent Times’ article (7/30, Parker-Pope) regarding the redefinition of certain types of cancers.

Read the letter here.